A Bayesian Estimation Procedure for One-Parameter Exponential Survival Distributions Facilitated by an Inverted Gamma Prior
- John Effiong Usen
- Emmanuel Emmanuel Asuk
- Godswill Itobo Egede
- 881-905
- Jun 14, 2025
- Mathematics
A Bayesian Estimation Procedure for One-Parameter Exponential Survival Distributions Facilitated by an Inverted Gamma Prior
John Effiong Usen*; Emmanuel Emmanuel Asuk; Godswill Itobo Egede
University of Cross River State, Calabar, Cross River State, Nigeria
*Corresponding Author
DOI: https://doi.org/10.51584/IJRIAS.2025.100500079
Received: 05 May 2025; Accepted: 09 May 2025; Published: 14 June 2025
ABSTRACT
A Bayesian estimation procedure for one-parameter exponential survival distributions facilitated by an inverted gamma prior was performed in this study using data obtained from data obtained from the University of Calabar Teaching Hospital (UCTH). The exponential survival distributions are just one amongst a number of distributions adopted for tackling problems in survival analysis, and may occur either in one parameter or two parameters under uncensored or censored conditions. The review of literature exposed the absence of studies addressing the need for an alternative procedure that carefully considered the peculiarities of the exponential survival distribution; hence, this study aimed to address this gap. Based on this, a Bayesian estimation technique was employed to estimate only the parameter of the one-parameter exponential survival distribution under uncensored and censored circumstances, with the survivorship and hazard functions deduced, thereafter. The results obtained showed that the parameter of the exponential survival distribution (λ) existed both for the one-parameter uncensored and censored cases of the exponential survival distribution, with known expressions. Both the MLE and Bayesian estimation results were simulated using real-life data, and the results showed near-convergence of the MLE and Bayesian estimation for unit values of the parameters of the inverted gamma prior used in the study.
Keywords: Bayesian Estimation Procedure, One-Parameter Exponential Survival Distributions, Inverted Gamma Prior
INTRODUCTION
Background of the study
In industries, the interest of process engineers may often be the estimation of the time available until a machine fails, while the interest of specialists in the clinical sciences may be the estimation of the time available: until a tumor reoccurs, until a cardiovascular death after some treatment intervention, until AIDS overwhelms an HIV infected person, etc. [1; 2]. Without the adoption of appropriate statistical know-how, these professionals may rely solely on intuition or experience for estimating such time [2]. The need to estimate such times non-intuitively, with high level of precision, has birthed the concept of survival analysis in statistics; and this technique has proven to be efficient [1; 2].
The area of survival analysis uses a host of techniques and statistical routines [3; 4]. As a statistical concept, survival analysis estimates the expected time duration until one or more events (such as death in biological organisms, and failure in mechanical systems) happen [5; 6]. Since its initiation in the early parts of 1940s, as a very useful bio-statistical tool, several statistical distributions like: exponential, Weibull, log-normal, gamma, generalized gamma, and log-logistic distributions, have all been adopted for studies on survival analysis, with the exponential survival distribution being the most commonly used distribution out of the lot [14; 15; 16; 17; 18]. More so, all these used distributions, as evidenced in literature, have had their parameters estimated via the general maximum likelihood estimation (MLE) routine, and this has no doubt produced formidable results; and with the parameter estimates for these distributions, their survival and hazard functions have been obtained [19; 20; 20; 22].
In recent times, to allow for advancements in statistical theory along the direction of exploring alternative estimation routines to the MLE, researchers have begun to attempt the adoption of Bayesian routine for achieving all (and even more) of what the MLE has been used to achieve with the afore-mentioned survival distributions [23; 24; 25; 26]. But one encountered problem, among several, has remained the nature of prior (informative or non-informative), and the suitability of prior (be it the: gamma, inverted gamma, Rayleigh, etc.) to be used [28; 29; 31]. In this study, an informative prior (the inverted gamma distribution) has been adopted, not only for the aim of obtaining Bayesian estimates of the one-parameter exponential distribution, but also for making inference about their survivorship and hazard functions under censored and uncensored circumstances.
Statement of the problem
One of the most commonly used distributions in survival analysis is the exponential survival distribution, be it for the one-parameter case or two-parameter case (with or without covariates). As evidenced in literature, Maximum Likelihood Estimation (MLE) has been used a lot for estimating parameters of one-parameter and two-parameter exponential survival distributions, and for obtaining their survival and hazard functions. And, although the MLE procedure has remained very efficient for achieving this, its usage yet restricts survival analysts to just one choice of estimation procedure. The absence of an attempt, in literature, to proffer the use of the Bayesian alternative to the MLE for achieving the same results, with a suitable informative prior, limits statistical theoretical advancement, going forward. Thus, this study is a foremost attempt in this regard.
Aim and objectives of the study
This study aims to perform a Bayesian estimation for one-parameter exponential survival distributions facilitated by an inverted gamma prior. In line with achieving the stated aim, the objectives of the study are to: (i) review the MLE procedure for obtaining the survivorship and hazard functions under (uncensored and censored conditions), (ii) adopt Bayesian estimation procedure for obtaining the survivorship and hazard functions (under uncensored and censored conditions), and (iii) simulate the MLE and Bayesian alternative on real-life data.
MATERIALS AND METHODS
MLE for data with right-censored observations
Suppose that persons were followed to death or censored in a study. Let ,
be the survival times observed from the
individuals, with
exact times and
right-censored times. Assume that the survival times follow a distribution with density function
, and survivorship function
, where
denotes unknown
parameters
in the distribution. If the survival time is discrete (that is, it is observed at discrete time only), then
represents the probability of observing
, and
represents the probability that the survival or event time is greater than
[7]. In other words,
and
represent the information that can be obtained respectively from an observed uncensored survival time and observed right-censored survival time [8]. Therefore, the product
represents the joint probability of observing the uncensored survival times, and
represents the joint probability of those right-censored survival times. The product of these two probabilities, denoted by
,
represents the joint probability of observing ,
[7].
A similar interpretation applies to continuous survival , called the likelihood function of
, which can also be interpreted as a measure of the likelihood of observing a specific set of survival times, namely:
,
, given a specific set of parameters
[7; 9]. The method of the MLE is to find an estimator of
that maximizes
(or which is most likely to have produced the observed data
,
) [8].
Taking the logarithm of , and denoting it by
, gives:
Then the MLE is a
in the set of
that maximizes
:
It is clear that is a solution of the following simultaneous equations, which are obtained by taking the derivative of
with respect to each
:
To obtain the MLE , one can use a numerical method. A commonly used numerical method is the Newton-Raphson iterative procedure, which can be summarized as follows [10; 12].
- Let the initial values
be zero; that is, let
- The changes for
at each subsequent step, denoted by
, is obtained by taking the second derivative of the log-likelihood function:
- Using
, the value of
at
step is
The iteration terminates at, say, the step if
, where
is a given precision, usually a very small value,
or
[11]. Then the MLE
is defined as
The estimated covariance matrix of the MLE is given by
One of the good properties of a MLE is that if is the MLE of
, then
is the MLE of
if
is a finite function and need not be one-to-one [10; 30].
The estimated confidence interval for any parameter
is
where is the
diagonal element of
and
is the
percentile point of the standard normal distribution
. For a finite function
of
, the estimated
confidence interval for
is its respective range
on the confidence interval in equation (6) [10; 30], that is,
In case is monotone in
, the estimated
confidence interval for
is
MLE for data with right-, left-, and interval-censored observations
If the survival times observed for the
persons consist of uncensored left-, right-, and interval-censored observations, then the estimation procedures are similar [10; 30]. Assume that the survival times follow a distribution with density function
and the survivorship function
, where
denotes all unknown parameters of the distribution. Then the log-likelihood function is given by:
where the first sum is over the uncensored observations, the second sum is over the right-censored observations, the third sum is over the left-censored observations, and the last sum is over the interval-censored observations, with as the lower end of a censoring interval [10; 30]. The other steps for obtaining the MLE
of
are similar to the steps shown in section (3.1) by substituting for the log-likelihood function defined in equation (1) with the log-likelihood function in equation (9).
MLE on the one-parameter exponential survival distribution
The one-parameter exponential distribution has the following function;
survivorship function;
and hazard function;
where ,
. Obviously, the exponential distribution is characterized by one parameter,
. The estimation of
by maximum likelihood methods for data without censored observations will be given first followed by the case with censored observations.
Maximum likelihood estimation of for data without censored observations
Suppose that there are persons in the study and everyone is followed to death or failure. Let
be the exact survival times of the
people. The likelihood function, using (10) and (1), is:
and the log-likelihood function is
From equation (2), the MLE of is
Since the mean of the exponential distribution is
and a MLE is invariant under a one-to-one transformation, the MLE of
is
It can be shown that has an exact chi-square distribution with
degrees of freedom. Since
and
an exact
confidence interval for
is
where is the
percentage point of the chi-square distribution with
degrees of freedom; that is,
[10; 12]. When
is large (say,
),
is approximately normally distributed with mean
and variance
[10; 12]. Thus, an approximate
confidence interval for
is
where is the
percentage point,
, of the standard normal distribution [10; 12]. Since
has an exact chi-square distribution with
degrees of freedom, an exact
confidence interval for the mean survival time is
Maximum likelihood estimation of for data with censored observations
We first consider singly censored and then progressively censored data. Suppose that without loss of generality, the study or experiment begins at time zero with a total of subjects. Survival times are recorded and the data become available when the subjects die one after the other in such a way that the shortest time comes first, the second shortest time comes second, and so on [12; 27]. Suppose that the investigator has decided to terminate the study after
out of the
subjects have and to sacrifice the remaining
subjects at that time. Then the survival times for the
subjects are
where a superscript plus indicates a sacrificed subject, and thus is a censored observation. In this case,
and
are fixed values and all of the
censored observations are equal [12; 27].
The likelihood function, using equations (1), (10) and (11), is
and from equation (2), the MLE of is
The mean survival time can then be estimated by
It has been shown that has a chi-square distribution with
degrees of freedom [12; 27]. The mean and variance of
are
and
respectively. The
confidence interval for
is
When is large, the distribution of
is approximately normal with mean
and variance
[12; 27]. An approximate
confidence interval for
is then
It has also been shown that has a chi-square distribution with
degrees of freedom [12; 27]. Thus, a
confidence interval for
is
They also develop test procedures for the hypothesis against the alternative
. One of their rules of action is to accept
if
and reject
if
, where
and
is the significance level [12]. Or if the estimated mean survival time calculated from equation (20) is greater than
, the hypothesis
is rejected at the
level of significance [27].
A slightly different situation may arise in laboratory experiments. Instead of terminating the study after the death, the experimenter may stop after a period of time
, which may be six months or a year [27]. If we denote the number of deaths between 0 and
as
, the survival data may look as follows:
Mathematical derivations of the MLE of and
are exactly the same and equation (19) can still be used [27].
Progressively censored data come more frequently from clinical studies where patients are entered at different times and the study lasts a predetermined period of time [13]. Suppose that the study begins at time 0 and terminates at time and there are a total of
people entered [12; 27]. Let
be the number of patients who die before or at time
and
the number of patients who are lost to follow-up during the study period or remain alive at time
. The data look as follows:
. Ordering the
uncensored observations according to their magnitude, we have:
The likelihood function, using equations (1), (10) and (11), is
and the log-likelihood function is
and from equation (2), the MLE of the parameter is
Consequently,
is the MLE of the mean survival time [12; 27]. The sum of all of the observations, censored and uncensored, divided by the number of uncensored observations, gives the MLE of the mean survival time [12; 27]. To overcome the mathematical difficulties arising when all of the observations are censored . [7] defines
In practice, this estimate has little value.
The distribution of for large
is approximately normal with mean
and variance:
where is the time that the
person is under observations. In other words,
is computed from the time
person enters the study to the end of the study [12; 27]. If the observations times
are not known, the following quick estimate of
can be used [7].
Thus, an approximate confidence interval for
is, by (6),
The distribution of is approximately normal with mean
and variance:
Again, a quick estimate is
An approximate confidence interval for
is then, by (6),
Informative and non-informative priors
Let be a prior distribution for the parameter
of a distribution. Then, according to [16; 17],
- The distribution is an informative prior, if it biases the parameter towards particular values (i.e., an informative prior expresses specific, definite information about a variable);
- The distribution is a non-informative prior, if it does not influence the posterior hyperparameters (i.e., an uninformative prior, or diffuse prior, expresses unclear or general information about a variable).
The inverted gamma prior
If a random variable has the gamma distribution
, then the random variable
has the inverted gamma distribution
with the density function [16; 17].
For , we obtain
And,
The Bayesian estimation procedure
Let be a random sample from the density
. Before taking the sample, the distribution of
,
(called a prior distribution), is assumed known. The objective in Bayesian estimation of the parameter
is to determine the distribution
(known as the posterior distribution) after taking the sample.
Let us consider the conditional distribution
Substituting for equation (34) in equation (35) gives,
But
Therefore,
Putting equation (37) into equation (36) gives
Since we are taking a random sample of this distribution
Hence, equation (38) becomes:
The above equation (39) gives as the posterior Bayes distribution with respect to the prior distribution
.
Hence,
is called the posterior Bayes estimator with respect to the prior distribution ; where
is any function of
.
An outline of the research estimation procedure
The proposed Bayesian alternative will be implemented with the procedure below.
Step 1: Determine an appropriate prior .
In this case, the appropriate prior for the one-parameter exponential distribution is the inverted gamma distribution with parameters and
. That is,
Step 2: Obtain the Bayesian estimate of for data without censored observations.
Here the procedure involved requires that we obtain thus:
where, denotes the likelihood function. That is,
Step 3: Obtain the Bayesian estimate of for data with censored observations.
Here the procedure involved requires that we obtain thus:
where, denotes the likelihood function. That is,
RESULTS
Bayesian estimation for the one-parameter uncensored case
Theorem 1
If is an uncensored exponential random variable with parameter
, and the prior density of
is the inverted gamma with parameters
and
, then the estimate of
provided by the posterior is
, given by:
Proof 1:
Now, ;
is the posterior distribution of the parameter
. Let
be the likelihood function. Then,
Hence,
Let
Since the mean of the exponential distribution is
and Bayesian estimation is invariant under one-to-one transformation, then the Bayesian estimate of
is given by:
Therefore, the following axiom is established:
Axiom 1:
(a) The estimate of the survivorship function is given as:
(b) The estimate of the hazard function is given as:
Bayesian estimation for the one-parameter censored case
Theorem 2:
If is a censored exponential random variable with parameter
, and the prior density of
is the inverted gamma with parameters
and
, then the estimate of
provided by the posterior is
, given by:
Proof 2:
Now, ;
is the posterior distribution of the parameter
. Let
be the likelihood function. Then,
Hence,
Let
Again, since the mean of the exponential distribution is
and Bayesian estimation is invariant under one-to-one transformation, then the Bayesian estimate of
is given by:
Therefore, the following axiom is established:
Axiom 2:
(a) The estimate of the survivorship function is given as:
(b) The estimate of the hazard function is given as:
Simulation
One-parameter exponential distribution without censored observations
Given the remission times in months for 734 HIV/AIDS patients (Appendix 1). Assuming that remission duration follows the exponential distribution, we can estimate the parameter as follows.
Simulating the one-parameter uncensored case, via the MLE, the relapse rate, , is
per week
The mean remission time is then
weeks.
Using the analytical procedures given above, confidence intervals for and
can also be obtained.
A 95% confidence interval for the relapse rate , following
is approximately
A 95% confidence interval for the mean remission time following is
Once the parameter is estimated, other estimates can be obtained. For example, the probability of staying in remission for at least 20 months, can be estimated from:
However, simulating the one-parameter uncensored case by Bayesian alternative, we have a Bayesian estimate of the relapse rate, , at
;
, gave results consistent with those which were obtained from the uncensored case (via existing method). And this is based on the convergence of the values. That is,
One-parameter exponential distribution with censored observations
A study is carried out on 312 AIDS patients. The study is terminated after half (156) of the AIDS are dead with the other half sacrificed at that time. The survival data of the 312 AIDS patients are shown in Appendix 2. Assuming that the failure of these AIDS patients follows an exponential distribution, the survival rate and mean survival time
via the MLE method are estimated, respectively, according to
And
By
per week
and weeks. A 95% confidence interval for
by
is
A 95% confidence interval for following
is
The probability of surviving a given time for the patients can be estimated from . For example, the probability that a patient exposed to AIDS will survive longer than 122 months is
The probability of dying in 122 months is then .
However, assuming that the failure of these AIDS patients follows an exponential distribution, the survival rate and mean survival time
via the Bayesian method are estimated, respectively, at
;
according to
Hence, per week and
weeks. A 95% confidence interval for
by
is
A 95% confidence interval for following
is
Similarly, the probability of surviving a given time for the patients can be estimated from . For example, the probability that a patient exposed to AIDS will survive longer than 122 months will now be:
The probability of dying in 122 months is then .
DISCUSSION
The results of this study are summarized in Table 1 and Table 2. These two tables respectively show the parameter estimates of using the maximum likelihood estimation and Bayesian estimation procedures under uncensored and censored circumstances. Here, Table 1 and Table 2 show that the parameter estimates of
exists and are non-zero. Consequently, this implies the existence of the survivorship and hazard functions.
For the one-parameter exponential distribution without censored observations, we note that at ;
, using the Bayesian approach gave results consistent with those which were obtained from the uncensored case through the MLE procedure as confirmed by the convergence of the
,
, interval and
values.
For the one-parameter exponential distribution with censored observations, we see that at ;
, using the Bayesian approach gave results with significant divergence from those which were obtained from the uncensored case based on the MLE method as confirmed by the divergence of the
,
, and interval
values.
CONCLUSION
In conclusion, this study has attempted a Bayesian estimation alternative to the MLE for estimating parameters of exponential survival distributions (in one parameter and two parameters) under uncensored and censored scenarios. Two axioms were deduced on what the survivorship and hazard functions are, for each of the estimated parameters. The results obtained from the one-parameter cases showed that known parameter estimates of , as well as the survivorship and hazard function, exists, and are similar to the results obtained via the MLE under certain values of the parameters of the prior used (in this case, the inverted gamma distribution).
Table 1 Maximum likelihood estimates for one-parameter exponential survival distribution
ET | Maximum Likelihood | |||
Sur. Dist. | Case | One parameter | ||
U | ||||
C |
ET = Estimation Technique; Sur. Dist. = Survival Distribution; U = Uncensored; C = Censored
Table 2 Bayesian estimates for one-parameter exponential survival distribution
ET | Bayesian | |||
Sur. Dist. | Case | One parameter | ||
U | ||||
C |
ET = Estimation Technique; Sur. Dist. = Survival Distribution; U = Uncensored; C = Censored
REFERENCES
- Abujarad, M. H., Abujarad, E. S. A. & Khan, A. A. (2019). Bayesian survival analysis of type I general exponential distributions. Annals of Data Science.
- Aelen, O. O. (1994). Effects of frailty in survival analysis. Statistical Methods in Medical Research, 12(5), 34-56.
- Ahmed, O. M. (2021). Bayesian estimations of exponential distributions based on interval-censored data with cure fraction. Hindawi Journal of Mathematics, Article ID: 9822870, 1-11.
- Aliyu, Y. & Usman, U. (2023). On bivariate Nadarajah-Haghighi distribution derived from Farlie-Gumbel-Morgenstern copula in the presence of covariates. Journal of the Nigerian Society of Physical Sciences, 5(2), 871.
- Al-Kutubi, H. S. & Ibrahim, N. A. (2009). Bayes estimator for exponential distribution with extension of Jeffrey’s prior information. Malaysian Journal of Mathematical Sciences, 3(2), 297-313.
- Amico, M. & Keilegom, I. V. (2018). Cure models in survival analysis. Annual Review of Statistics and its Applications, 5, 311-342.
- Bartholomew, D. J. (1957). A problem in life testing. Journal of the American Statistical Association, 52, 350-355.
- Belaghi, R. A., Asl, M. N., Alma, O. G., Singh, S. & Vasfi, M. (2019). Estimation and prediction for the Poisson-exponential distribution based on type-II censored data. American Journal of Mathematical and Management Sciences, 38(1), 96-115.
- Clark, T. G., Bradburn, M. J., Love, S. B. & Altman, D. G. (2003). Survival analysis part 1: Basic concepts and first analyses. British Journal of Cancer, 89, 232-238.
- Epstein, B. (1960). Estimation of the parameters of two-parameter exponential distribution from censored samples. Technometrics, 2, 403-406.
- Garcia, V., Marcel-Escobar, M., & Varquez-Polo, F. J. (2020). Generalizing exponential distributions using an extended Marshall-Olkin procedure. MDPI, 12(464), 1-15.
- Gehan, E. A. (1970). Unpublished notes on survival time studies. The University of Texas, M. D. Anderson Cancer Center, Houston, Texas.
- George, B. Seals, S. & Aban, I. (2014). Survival analysis and regression models. Journal of Nuclear Cardiology, 21(4), 686-694.
- Iddrisu, A., Alhassan, A. & Amidu, N. (2019). Survival analysis of birth defect infants and children with Pneumonia mortality in Ghana. Hidawi – Advances in Public Health, 1-7.
- Lin, J., Sinha, D., Lipsitz, S. & Polpo, A. (2012). Semiparametric Bayesian survival analysis using models with log-linear median. Biometrics, 68(14), 1136-1145.
- Kaushik, A. (2017). Bayesian estimation of the parameters of exponentiated exponential distribution under progressive interval type-1 censoring scheme with binomial removals. Journal of Statistics Applications and Processes, 6(1), 65-79.
- Khan, N. & Khan, A. A. (2018). Bayesian analysis of Topp-Leone generalized exponential distribution. Austrian Journal of Statistics, 47, 1-15.
- Kharazmi, O., Hamedani, G. G. & Cordeiro, G. M. (2023). Log-mean distribution: applications to medical data, survival regression, Bayesian and non-Bayesian discussion with MCMC algorithm. Journal of Applied Statistics, 50(5), 1152-1177.
- Khumar, D. (2014). Moment generating functions of generalized order statistics from extended type II generalized logistic distribution. Journal of Statistical Theory and Applications, 13(4), 273-288.
- Kim, J. (2016). Survival analysis. Research and Statistics, 33(4), 172-174.
- Kishan, R. & Sangal, P. K. (2022). Classical and Bayesian estimation in exponential power distribution under type-1 progressive hybrid censoring with binomial removals. Malaysian Journal of Mathematical Sciences, 16(3), 537-558.
- Okwuokenye, M. & Peace, K. E. (2015). Size and power of tests of hypotheses on survival parameters from the Lindley distribution with covariates. Austin Biometrics and Biostatistics, 2(4), 1026.
- Omer, M. E., Abubakar, M. R., Adam, M. B. & Mustafa, S. M. (2020). Cure models with exponentiated Weibull exponential distribution for the analysis of Melanoma patients. MDPI Mathematics, 8, 1-15.
- Ramadan, A. T., Tolba, A. H. & El-Desouky, B. S. (2021). Generalized power Akshaya distribution and its applications. Open Journal of Modeling and Simulation, 9(4), 323-338.
- Raqab, M. Z. & Madi, M. T. (2005). Bayesian inference for the generalized exponential distribution. Journal of Statistical Computation and Simulation, 75(10), 841-852.
- Rashwan, N. I. (2016). A note on Kumaraswamy exponentiated Rayleigh distribution. Journal of Statistical Theory and Applications, 15(3), 286-295.
- Shim, J. Y. (1997). Discount survival distributions for no covariate case. The Korean Communications in Statistics, 4(2), 491-496.
- Sundaram, N. (2011). Exponentiated exponential models for survival data. Indian Journal of Science and Technology, 4, 923-930.
- Yari, G. & Tondpour, Z. (2017). Estimation of the Burr XII-exponential distribution parameters. Applications and Applied Mathematics: An International Journal, 13(1), 47-66.
- Zelen, M. (1966). Applications of exponential methods to problems in cancer research. Journal of the Royal Statistical Society, Series A, 129, 368-398.
- Zhou, W. & Zhang, G. (2013). The generalized Kumaraswamy exponential distribution with application in survival analysis. Journal of Zhejiang University, 40(5).
APPENDICES
Appendix 1
Uncensored Data for Remission Times of HIV Patients
S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT |
1 | 126 | 36 | 130 | 71 | 130 | 106 | 131 | 141 | 128 | 176 | 134 | 211 | 139 | 246 | 135 |
2 | 130 | 37 | 135 | 72 | 130 | 107 | 135 | 142 | 133 | 177 | 134 | 212 | 132 | 247 | 137 |
3 | 138 | 38 | 130 | 73 | 128 | 108 | 132 | 143 | 134 | 178 | 127 | 213 | 128 | 248 | 134 |
4 | 131 | 39 | 135 | 74 | 137 | 109 | 138 | 144 | 129 | 179 | 132 | 214 | 135 | 249 | 133 |
5 | 139 | 40 | 135 | 75 | 135 | 110 | 138 | 145 | 134 | 180 | 130 | 215 | 127 | 250 | 129 |
6 | 132 | 41 | 132 | 76 | 132 | 111 | 137 | 146 | 137 | 181 | 134 | 216. | 135 | 251 | 140 |
7 | 127 | 42 | 139 | 77 | 127 | 112 | 135 | 147 | 134 | 182 | 138 | 217 | 133 | 252 | 132 |
8 | 138 | 43 | 137 | 78 | 127 | 113 | 139 | 148 | 127 | 183 | 126 | 218 | 130 | 253 | 136 |
9 | 132 | 44 | 132 | 79 | 130 | 114 | 129 | 149 | 139 | 184 | 125 | 219 | 128 | 254 | 138 |
10 | 130 | 45 | 138 | 80 | 129 | 115 | 131 | 150 | 134 | 185 | 134 | 220 | 131 | 255 | 128 |
11 | 134 | 46 | 129 | 81 | 137 | 116 | 139 | 151 | 136 | 186 | 129 | 221 | 136 | 256 | 134 |
12 | 138 | 47 | 136 | 82 | 131 | 117 | 131 | 152 | 133 | 187 | 126 | 222 | 135 | 257 | 135 |
13 | 127 | 48 | 130 | 83 | 130 | 118 | 129 | 153 | 131 | 188 | 131 | 223 | 135 | 258 | 139 |
14 | 136 | 49 | 133 | 84 | 134 | 119 | 131 | 154 | 130 | 189 | 131 | 224 | 131 | 259 | 137 |
15 | 134 | 50 | 133 | 85 | 128 | 120 | 140 | 155 | 139 | 190 | 135 | 225 | 126 | 260 | 135 |
16 | 130 | 51 | 133 | 86 | 139 | 121 | 126 | 156 | 137 | 191 | 135 | 226 | 128 | 261 | 132 |
17 | 138 | 52 | 137 | 87 | 131 | 122 | 140 | 157 | 135 | 192 | 130 | 227 | 132 | 262 | 132 |
18 | 132 | 53 | 129 | 88 | 135 | 123 | 134 | 158 | 136 | 193 | 132 | 228 | 135 | 263 | 133 |
19 | 130 | 54 | 135 | 89 | 127 | 124 | 133 | 159 | 133 | 194 | 133 | 229 | 127 | 264 | 136 |
20 | 133 | 55 | 125 | 90 | 135 | 125 | 141 | 160 | 133 | 195 | 133 | 230 | 133 | 265 | 133 |
21 | 135 | 56 | 133 | 91 | 136 | 126 | 133 | 161 | 126 | 196 | 131 | 231 | 137 | 266 | 137 |
22 | 136 | 57 | 136 | 92 | 132 | 127 | 134 | 162 | 131 | 197 | 132 | 232 | 133 | 267 | 136 |
23 | 130 | 58 | 130 | 93 | 134 | 128 | 131 | 163 | 131 | 198 | 137 | 233 | 130 | 268 | 140 |
24 | 131 | 59 | 129 | 94 | 137 | 129 | 135 | 164 | 136 | 199 | 133 | 234 | 134 | 269 | 130 |
25 | 138 | 60 | 132 | 95 | 130 | 130 | 129 | 165 | 138 | 200 | 131 | 235 | 129 | 270 | 138 |
26 | 130 | 61 | 127 | 96 | 140 | 131 | 133 | 166 | 137 | 201 | 139 | 236 | 135 | 271 | 130 |
27 | 140 | 62 | 137 | 97 | 128 | 132 | 140 | 167 | 129 | 202 | 136 | 237 | 129 | 272 | 135 |
28 | 137 | 63 | 140 | 98 | 128 | 133 | 134 | 168 | 139 | 203 | 137 | 238 | 132 | 273 | 125 |
29 | 135 | 64 | 139 | 99 | 136 | 134 | 132 | 169 | 133 | 204 | 139 | 239 | 134 | 274 | 132 |
30 | 134 | 65 | 135 | 100 | 127 | 135 | 130 | 170 | 137 | 205 | 127 | 240 | 137 | 275 | 130 |
31 | 131 | 66 | 133 | 101 | 133 | 136 | 139 | 171 | 131 | 206 | 134 | 241 | 132 | 276 | 133 |
32 | 137 | 67 | 130 | 102 | 139 | 137 | 133 | 172 | 130 | 207 | 137 | 242 | 132 | 277 | 136 |
33 | 138 | 68 | 136 | 103 | 127 | 138 | 130 | 173 | 132 | 208 | 135 | 243 | 133 | 278 | 133 |
34 | 126 | 69 | 128 | 104 | 133 | 139 | 137 | 174 | 137 | 209 | 133 | 244 | 140 | 279 | 127 |
35 | 136 | 70 | 129 | 105 | 134 | 140 | 135 | 175 | 139 | 210 | 137 | 245 | 129 | 280 | 131 |
S/N = Serial Numbers; RT = Remission Times
Data Obtained from University of Calabar Teaching Hospital (UCTH)
S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT |
281 | 131 | 316 | 137 | 351 | 136 | 386 | 131 | 421 | 128 | 456 | 139 | 491 | 135 | 526 | 137 |
282 | 134 | 317 | 132 | 352 | 127 | 387 | 134 | 422 | 134 | 457 | 130 | 492 | 139 | 527 | 131 |
283 | 127 | 318 | 134 | 353 | 128 | 388 | 131 | 423 | 133 | 458 | 127 | 493 | 129 | 528 | 131 |
284 | 139 | 319 | 133 | 354 | 132 | 389 | 135 | 424 | 134 | 459 | 134 | 494 | 124 | 529 | 140 |
285 | 126 | 320 | 133 | 355 | 138 | 390 | 131 | 425 | 135 | 460 | 136 | 495 | 139 | 530 | 137 |
286 | 132 | 321 | 138 | 356 | 133 | 391 | 127 | 426 | 140 | 461 | 133 | 496 | 136 | 531 | 131 |
287 | 140 | 322 | 132 | 357 | 129 | 392 | 133 | 427 | 138 | 462 | 135 | 497 | 139 | 532 | 130 |
288 | 135 | 323 | 136 | 358 | 129 | 393 | 126 | 428 | 131 | 463 | 135 | 498 | 141 | 533 | 133 |
289 | 133 | 324 | 140 | 359 | 135 | 394 | 131 | 429 | 134 | 464 | 127 | 499 | 136 | 534 | 134 |
290 | 134 | 325 | 138 | 360 | 133 | 395 | 131 | 430 | 130 | 465 | 131 | 500 | 141 | 535 | 127 |
291 | 139 | 326 | 131 | 361 | 131 | 396 | 135 | 431 | 132 | 466 | 139 | 501 | 131 | 536 | 130 |
292 | 129 | 327 | 136 | 362 | 130 | 397 | 138 | 432 | 129 | 467 | 135 | 502 | 132 | 537 | 133 |
293 | 128 | 328 | 133 | 363 | 127 | 398 | 130 | 433 | 132 | 468 | 135 | 503 | 132 | 538 | 128 |
294 | 137 | 329 | 138 | 364 | 133 | 399 | 131 | 434 | 132 | 469 | 129 | 504 | 130 | 539 | 129 |
295 | 135 | 330 | 137 | 365 | 131 | 400 | 131 | 435 | 130 | 470 | 139 | 505 | 127 | 540 | 132 |
296 | 131 | 331 | 132 | 366 | 132 | 401 | 140 | 436 | 131 | 471 | 134 | 506 | 131 | 541 | 131 |
297 | 141 | 332 | 130 | 367 | 129 | 402 | 136 | 437 | 140 | 472 | 136 | 507 | 131 | 542 | 129 |
298 | 130 | 333 | 127 | 368 | 128 | 403 | 129 | 438 | 130 | 473 | 140 | 508 | 133 | 543 | 133 |
299 | 133 | 334 | 138 | 369 | 135 | 404 | 131 | 439 | 132 | 474 | 133 | 509 | 126 | 544 | 133 |
300 | 134 | 335 | 138 | 370 | 135 | 405 | 137 | 440 | 133 | 475 | 135 | 510 | 128 | 545 | 137 |
301 | 127 | 336 | 130 | 371 | 135 | 406 | 135 | 441 | 132 | 476 | 128 | 511 | 135 | 546 | 135 |
302 | 134 | 337 | 130 | 372 | 125 | 407 | 130 | 442 | 133 | 477 | 130 | 512 | 131 | 547 | 137 |
303 | 132 | 338 | 133 | 373 | 137 | 408 | 136 | 443 | 137 | 478 | 131 | 513 | 125 | 548 | 130 |
304 | 124 | 339 | 141 | 374 | 134 | 409 | 138 | 444 | 125 | 479 | 133 | 514 | 134 | 549 | 135 |
305 | 132 | 340 | 128 | 375 | 133 | 410 | 133 | 445 | 135 | 480 | 128 | 515 | 137 | 550 | 133 |
306 | 137 | 341 | 137 | 376 | 137 | 411 | 128 | 446 | 133 | 481 | 136 | 516 | 132 | 551 | 134 |
307 | 136 | 342 | 132 | 377 | 136 | 412 | 129 | 447 | 135 | 482 | 129 | 517 | 129 | 552 | 130 |
308 | 134 | 343 | 126 | 378 | 135 | 413 | 131 | 448 | 135 | 483 | 128 | 518 | 126 | 553 | 125 |
309 | 134 | 344 | 128 | 379 | 137 | 414 | 137 | 449 | 130 | 484 | 129 | 519 | 136 | 554 | 136 |
310 | 135 | 345 | 136 | 380 | 133 | 415 | 131 | 450 | 135 | 485 | 137 | 520 | 132 | 555 | 134 |
311 | 133 | 346 | 134 | 381 | 130 | 416 | 129 | 451 | 135 | 486 | 135 | 521 | 130 | 556 | 140 |
312 | 133 | 347 | 136 | 382 | 131 | 417 | 129 | 452 | 133 | 487 | 127 | 522 | 139 | 557 | 131 |
313 | 135 | 348 | 128 | 383 | 133 | 418 | 132 | 453 | 125 | 488 | 131 | 523 | 131 | 558 | 132 |
314 | 128 | 349 | 139 | 384 | 129 | 419 | 134 | 454 | 134 | 489 | 135 | 524 | 133 | 559 | 137 |
315 | 130 | 350 | 133 | 385 | 131 | 420 | 126 | 455 | 132 | 490 | 128 | 525 | 136 | 560 | 139 |
S/N = Serial Numbers; RT = Remission Times
Data Obtained from University of Calabar Teaching Hospital (UCTH)
S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT | S/N | RT |
561 | 126 | 596 | 140 | 631 | 137 | 666 | 135 | 701 | 133 | 736 | – | 771 | – | 806 | – |
562 | 130 | 597 | 134 | 632 | 137 | 667 | 136 | 702 | 132 | 737 | – | 772 | – | 807 | – |
563 | 126 | 598 | 134 | 633 | 127 | 668 | 138 | 703 | 130 | 738 | – | 773 | – | 808 | – |
564 | 127 | 599 | 127 | 634 | 133 | 669 | 130 | 704 | 137 | 739 | – | 774 | – | 809 | – |
565 | 125 | 600 | 138 | 635 | 133 | 670 | 127 | 705 | 137 | 740 | – | 775 | – | 810 | – |
566 | 135 | 601 | 135 | 636 | 131 | 671 | 136 | 706 | 129 | 741 | – | 776 | – | 811 | – |
567 | 133 | 602 | 136 | 637 | 127 | 672 | 139 | 707 | 137 | 742 | – | 777 | – | 812 | – |
568 | 140 | 603 | 140 | 638 | 139 | 673 | 134 | 708 | 134 | 743 | – | 778 | – | 813 | – |
569 | 136 | 604 | 129 | 639 | 133 | 674 | 134 | 709 | 137 | 744 | – | 779 | – | 814 | – |
570 | 135 | 605 | 134 | 640 | 136 | 675 | 132 | 710 | 130 | 745 | – | 780 | – | 815 | – |
571 | 132 | 606 | 137 | 641 | 138 | 676 | 134 | 711 | 134 | 746 | – | 781 | – | 816 | – |
572 | 135 | 607 | 130 | 642 | 134 | 677 | 136 | 712 | 127 | 747 | – | 782 | – | 817 | – |
573 | 129 | 608 | 130 | 643 | 132 | 678 | 130 | 713 | 133 | 748 | – | 783 | – | 818 | – |
574 | 139 | 609 | 134 | 644 | 137 | 679 | 133 | 714 | 131 | 749 | – | 784 | – | 819 | – |
575 | 128 | 610 | 133 | 645 | 132 | 680 | 138 | 715 | 128 | 750 | – | 785 | – | 820 | – |
576 | 132 | 611 | 140 | 646 | 132 | 681 | 140 | 716 | 128 | 751 | – | 786 | – | 821 | – |
577 | 133 | 612 | 135 | 647 | 130 | 682 | 135 | 717 | 130 | 752 | – | 787 | – | 822 | – |
578 | 130 | 613 | 140 | 648 | 139 | 683 | 139 | 718 | 129 | 753 | – | 788 | – | 823 | – |
579 | 139 | 614 | 133 | 649 | 129 | 684 | 129 | 719 | 133 | 754 | – | 789 | – | 824 | – |
580 | 133 | 615 | 135 | 650 | 139 | 685 | 131 | 720 | 130 | 755 | – | 790 | – | 825 | – |
581 | 130 | 616 | 136 | 651 | 134 | 686 | 126 | 721 | 133 | 756 | – | 791 | – | 826 | – |
582 | 128 | 617 | 134 | 652 | 140 | 687 | 133 | 722 | 138 | 757 | – | 792 | – | 827 | – |
583 | 136 | 618 | 130 | 653 | 132 | 688 | 132 | 723 | 133 | 758 | – | 793 | – | 828 | – |
584 | 137 | 619 | 138 | 654 | 133 | 689 | 130 | 724 | 137 | 759 | – | 794 | – | 829 | – |
585 | 132 | 620 | 139 | 655 | 140 | 690 | 128 | 725 | 137 | 760 | – | 795 | – | 830 | – |
586 | 126 | 621 | 138 | 656 | 140 | 691 | 139 | 726 | 139 | 761 | – | 796 | – | 831 | – |
587 | 135 | 622 | 139 | 657 | 137 | 692 | 137 | 727 | 133 | 762 | – | 797 | – | 832 | – |
588 | 133 | 623 | 137 | 658 | 128 | 693 | 133 | 728 | 134 | 763 | – | 798 | – | 833 | – |
589 | 139 | 624 | 130 | 659 | 139 | 694 | 132 | 729 | 135 | 764 | – | 799 | – | 834 | – |
590 | 139 | 625 | 136 | 660 | 130 | 695 | 135 | 730 | 140 | 765 | – | 800 | – | 835 | – |
591 | 135 | 626 | 132 | 661 | 137 | 696 | 132 | 731 | 139 | 766 | – | 801 | – | 836 | – |
592 | 134 | 627 | 135 | 662 | 132 | 697 | 131 | 732 | 139 | 767 | – | 802 | – | 837 | – |
593 | 135 | 628 | 134 | 663 | 130 | 698 | 137 | 733 | 125 | 768 | – | 803 | – | 838 | – |
594 | 136 | 629 | 131 | 664 | 130 | 699 | 129 | 734 | 129 | 769 | – | 804 | – | 839 | – |
595 | 132 | 630 | 127 | 665 | 132 | 700 | 134 | 735 | – | 770 | – | 805 | – | 840 | – |
S/N = Serial Numbers; RT = Remission Times
Data Obtained from University of Calabar Teaching Hospital (UCTH)
Appendix 2
Censored Data for AIDS Patients
S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST |
1 | 113 | 36 | 72 | 71 | 103 | 106 | 80 | 141 | 8 | 176 | 125+ | 211 | 125+ | 246 | 125+ |
2 | 5 | 37 | 125 | 72 | 71 | 107 | 6 | 142 | 34 | 177 | 125+ | 212 | 125+ | 247 | 125+ |
3 | 53 | 38 | 5 | 73 | 92 | 108 | 91 | 143 | 2 | 178 | 125+ | 213 | 125+ | 248 | 125+ |
4 | 6 | 39 | 1 | 74 | 60 | 109 | 51 | 144 | 115 | 179 | 125+ | 214 | 125+ | 249 | 125+ |
5 | 14 | 40 | 85 | 75 | 65 | 110 | 66 | 145 | 73 | 180 | 125+ | 215 | 125+ | 250 | 125+ |
6 | 102 | 41 | 40 | 76 | 90 | 111 | 116 | 146 | 43 | 181 | 125+ | 216 | 125+ | 251 | 125+ |
7 | 75 | 42 | 107 | 77 | 65 | 112 | 98 | 147 | 5 | 182 | 125+ | 217 | 125+ | 252 | 125+ |
8 | 3 | 43 | 5 | 78 | 82 | 113 | 81 | 148 | 42 | 183 | 125+ | 218 | 125+ | 253 | 125+ |
9 | 61 | 44 | 66 | 79 | 49 | 114 | 69 | 149 | 5 | 184 | 125+ | 219 | 125+ | 254 | 125+ |
10 | 23 | 45 | 102 | 80 | 23 | 115 | 33 | 150 | 12 | 185 | 125+ | 220 | 125+ | 255 | 125+ |
11 | 39 | 46 | 45 | 81 | 87 | 116 | 60 | 151 | 4 | 186 | 125+ | 221 | 125+ | 256 | 125+ |
12 | 8 | 47 | 80 | 82 | 60 | 117 | 83 | 152 | 121 | 187 | 125+ | 222 | 125+ | 257 | 125+ |
13 | 25 | 48 | 74 | 83 | 25 | 118 | 119 | 153 | 100 | 188 | 125+ | 223 | 125+ | 258 | 125+ |
14 | 1 | 49 | 57 | 84 | 3 | 119 | 27 | 154 | 75 | 189 | 125+ | 224 | 125+ | 259 | 125+ |
15 | 59 | 50 | 62 | 85 | 11 | 120 | 122 | 155 | 60 | 190 | 125+ | 225 | 125+ | 260 | 125+ |
16 | 1 | 51 | 89 | 86 | 36 | 121 | 79 | 156 | 1 | 191 | 125+ | 226 | 125+ | 261 | 125+ |
17 | 80 | 52 | 109 | 87 | 84 | 122 | 0 | 157 | 125+ | 192 | 125+ | 227 | 125+ | 262 | 125+ |
18 | 85 | 53 | 12 | 88 | 70 | 123 | 54 | 158 | 125+ | 193 | 125+ | 228 | 125+ | 263 | 125+ |
19 | 1 | 54 | 100 | 89 | 84 | 124 | 115 | 159 | 125+ | 194 | 125+ | 229 | 125+ | 264 | 125+ |
20 | 10 | 55 | 104 | 90 | 5 | 125 | 119 | 160 | 125+ | 195 | 125+ | 230 | 125+ | 265 | 125+ |
21 | 110 | 56 | 59 | 91 | 96 | 126 | 0 | 161 | 125+ | 196 | 125+ | 231 | 125+ | 266 | 125+ |
22 | 55 | 57 | 101 | 92 | 54 | 127 | 16 | 162 | 125+ | 197 | 125+ | 232 | 125+ | 267 | 125+ |
23 | 1 | 58 | 75 | 93 | 65 | 128 | 11 | 163 | 125+ | 198 | 125+ | 233 | 125+ | 268 | 125+ |
24 | 89 | 59 | 94 | 94 | 25 | 129 | 10 | 164 | 125+ | 199 | 125+ | 234 | 125+ | 269 | 125+ |
25 | 33 | 60 | 102 | 95 | 46 | 130 | 16 | 165 | 125+ | 200 | 125+ | 235 | 125+ | 270 | 125+ |
26 | 57 | 61 | 55 | 96 | 6 | 131 | 7 | 166 | 125+ | 201 | 125+ | 236 | 125+ | 271 | 125+ |
27 | 5 | 62 | 71 | 97 | 25 | 132 | 95 | 167 | 125+ | 202 | 125+ | 237 | 125+ | 272 | 125+ |
28 | 106 | 63 | 105 | 98 | 10 | 133 | 19 | 168 | 125+ | 203 | 125+ | 238 | 125+ | 273 | 125+ |
29 | 29 | 64 | 99 | 99 | 47 | 134 | 1 | 169 | 125+ | 204 | 125+ | 239 | 125+ | 274 | 125+ |
30 | 9 | 65 | 75 | 100 | 18 | 135 | 86 | 170 | 125+ | 205 | 125+ | 240 | 125+ | 275 | 125+ |
31 | 46 | 66 | 6 | 101 | 83 | 136 | 5 | 171 | 125+ | 206 | 125+ | 241 | 125+ | 276 | 125+ |
32 | 5 | 67 | 99 | 102 | 91 | 137 | 8 | 172 | 125+ | 207 | 125+ | 242 | 125+ | 277 | 125+ |
33 | 115 | 68 | 61 | 103 | 55 | 138 | 63 | 173 | 125+ | 208 | 125+ | 243 | 125+ | 278 | 125+ |
34 | 51 | 69 | 28 | 104 | 72 | 139 | 83 | 174 | 125+ | 209 | 125+ | 244 | 125+ | 279 | 125+ |
35 | 68 | 70 | 106 | 105 | 97 | 140 | 9 | 175 | 125+ | 210 | 125+ | 245 | 125+ | 280 | 125+ |
S/N = Serial Numbers; ST = Survival Times
Data Obtained from University of Calabar Teaching Hospital (UCTH)
S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST | S/N | ST |
281 | 125+ | ||||||||||||||
282 | 125+ | ||||||||||||||
283 | 125+ | ||||||||||||||
284 | 125+ | ||||||||||||||
285 | 125+ | ||||||||||||||
286 | 125+ | ||||||||||||||
287 | 125+ | ||||||||||||||
288 | 125+ | ||||||||||||||
289 | 125+ | ||||||||||||||
290 | 125+ | ||||||||||||||
291 | 125+ | ||||||||||||||
292 | 125+ | ||||||||||||||
293 | 125+ | ||||||||||||||
294 | 125+ | ||||||||||||||
295 | 125+ | ||||||||||||||
296 | 125+ | ||||||||||||||
297 | 125+ | ||||||||||||||
298 | 125+ | ||||||||||||||
299 | 125+ | ||||||||||||||
300 | 125+ | ||||||||||||||
301 | 125+ | ||||||||||||||
302 | 125+ | ||||||||||||||
303 | 125+ | ||||||||||||||
304 | 125+ | ||||||||||||||
305 | 125+ | ||||||||||||||
306 | 125+ | ||||||||||||||
307 | 125+ | ||||||||||||||
308 | 125+ | ||||||||||||||
309 | 125+ | ||||||||||||||
310 | 125+ | ||||||||||||||
311 | 125+ | ||||||||||||||
312 | 125+ | ||||||||||||||
313 | – | ||||||||||||||
314 | – | ||||||||||||||
315 | – |
S/N = Serial Numbers; ST = Survival Times
Data Obtained from University of Calabar Teaching Hospital (UCTH)